Tonic Versus Burst DR(TM) Epidural Motor Cortex Stimulation for Neuropathic Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-15

Study Completion Date

2024-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidural stimulation of the primary motor cortex (PMC) is indicated for the relief of neuropathic pain refractory to pharmacological treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness Analysis of Ultrasound-guided Intratissue Percutaneous Electrolysis (EPI) in Patient With Chronic Low Back Pain

NCT04290221

Chronic Low-back Pain

COMPLETED NA

Study on the Efficacy of Non-invasive Spinal Cord Electrical Stimulation in Neuropathic Pain

NCT07046143

Neuropathic Pain

ENROLLING_BY_INVITATION NA

Pilot Study in Order to Evaluate Disconfort Among Outpatients Using actiTENS for Neuropathic Pain vs TENS ECO 2.

NCT03877016

Neuropathic Pain

COMPLETED NA

Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis

NCT01944150

Limbs Arthrosis Non Arthrosic Limbs Arthralgia Chronic Lomboradiculalgia +7 more

COMPLETED NA

Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)

NCT06499220

Chronic Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of this study is to compare the analgesic effect of two distinct waveforms (i.e. tonic versus Burst DR(TM)) delivered by an epidural stimulator of the (primary) motor cortex in patients suffering from neuropathic pain resistant to the best pharmacological treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuropathic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tonic then Burst DR(TM)

Tonic Motor Cortex Stimulation (MCS) for 3 months then Burst DR(TM) MCS for 3 months

Retrospective analysis of patients' choice

Intervention Type OTHER

Retrospective analysis of patients' choice of tonic or Burst DR(TM) waves for their analgesic effect.

Burst DR(TM) then tonic

Burst DR(TM) MCS for 3 months then tonic MCS for 3 months

Retrospective analysis of patients' choice

Intervention Type OTHER

Retrospective analysis of patients' choice of tonic or Burst DR(TM) waves for their analgesic effect.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retrospective analysis of patients' choice

Retrospective analysis of patients' choice of tonic or Burst DR(TM) waves for their analgesic effect.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients suffering from neuropathic pain refractory to best pharmacological treatment, operated on for MCS with an internal pulse generator (IPG) capable of delivering both tonic and Burst DR(TM) stimulation waveforms.